Sermorelin Satisfaction Trends Over Time: What Real Users and Clinical Data Actually Show

HealthRX.com

Trials measured growth and hormones, not satisfaction over time

Print or save as PDF

See the public record for Sermorelin

  • What it is / a 29-amino-acid GHRH analogue, not growth hormone [4]
  • Approval status / Geref, discontinued 2008; approvals withdrawn 2009 [5]
  • Sold today as / a compounded product, not FDA-approved [6]
  • Trial follow-up / 110 children treated for up to 1 year; a review also describes limited data from a few children after 36 months [1][4]
  • Height velocity in that trial / 4.1 to 8.0 to 7.2 cm/yr [1]
  • Adult trials / 14 days and 6 weeks [2][3]

Is there published data on satisfaction over time?

The trials described on this page report growth, hormone and body-composition outcomes, not satisfaction. Online reviews may describe changes over time, but these studies do not establish when people begin to feel a benefit or when any perceived benefit peaks.

Sermorelin prompts the pituitary to release the body's own growth hormone; it is not growth hormone [4]. In 30 healthy men aged 19 to 43, an intravenous dose cleared quickly yet growth hormone stayed raised for about 3 hours [7].

What people on Reddit report

Two firsthand replies in one forum thread asking whether sermorelin is worth using. They disagree on whether it works given time.

Big0Ben209 · PeptideForum

It's a gentle GHRH, good sleep, can work if you give it time to support better recovery and muscle growth.

Says it is gentle and can help with sleep and recovery, but only if given time to work.

Read the source discussion

GoDawgs206 · PeptideForum

No hype it sucks. There are multiple peptides that are way better and do the same thing. SERM is old, the newer ones are way better. Ipamorelin, cjc-1295, Tesamorelin

Says sermorelin is outdated and that other peptides work better for the same goal.

Read the source discussion

The one-year trial measured height

An open-label, multicenter study enrolled 110 previously untreated prepubertal children with growth hormone deficiency, 86 evaluable, given 30 micrograms per kg subcutaneously at bedtime for up to 1 year [1]. Height velocity rose from 4.1 cm/yr at baseline to 8.0 cm/yr at 6 months and 7.2 cm/yr at 12 months, and 74% were good responders at 6 months [1]. Height velocity, bone age and safety measures were monitored every 3 to 6 months; satisfaction was not among the listed outcome measures [1]. A review of sermorelin in these children notes limited data suggesting the height-velocity effect was maintained for 36 months of continued treatment in a few children [4].

The adult studies were short

Ten healthy men with a mean age of 68 took 0.5 mg and 1 mg of GHRH(1-29) twice daily for 14 days each, in random order, compared with nine men aged about 26; at 1 mg, 24-hour growth hormone and IGF-I rose to levels not significantly different from the young men [2].

Eleven men aged 64 to 76 self-injected 2 mg nightly for 6 weeks; nocturnal growth hormone rose, and two of six strength measures and an abdominal-crunch endurance test improved, but IGF-I and DEXA measures of muscle and fat did not change [3].

Those were study doses, not current approved doses [1][2][3]. The adult studies lasted 14 days and 6 weeks, so they did not evaluate outcomes beyond those periods [2][3].

Tolerability and approval status

In the 1-year pediatric study, no adverse changes appeared in general biochemistry or hormone tests, fasting glucose did not change, IGF-I was not excessively raised, and sermorelin was well tolerated overall [1].

Geref held the only sermorelin approvals: a 0.05 mg diagnostic product (1990) and 0.5 mg and 1 mg vials for growth failure in children with idiopathic growth hormone deficiency (1997) [5]. The maker discontinued both in 2008 and asked FDA to withdraw the applications; approval ended June 18, 2009, and in 2013 FDA determined Geref was not withdrawn for safety or effectiveness reasons [5]. Sermorelin sold in the US now is compounded, and compounded drugs are not FDA-approved [6].

Check what you know

Think you have it? Try 4 quick questions and see what the article says.

1. According to the article, how does sermorelin relate to growth hormone?

Question 1 of 4

Score: 0 right, 0 of 4 answered

Questions worth asking

Choose the questions you want to keep

Did any trial measure how people felt on sermorelin?
Not in the studies described on this page. The pediatric study tracked growth, bone age and safety measures [1]. The 14-day adult study measured hormone levels [2]. The 6-week adult study measured hormone levels, muscle strength and endurance, and body composition [3].
How quickly did the trials show changes?
In children, height velocity went from 4.1 cm/yr to 8.0 cm/yr at 6 months and 7.2 cm/yr at 12 months [1]. In older men, 24-hour growth hormone and IGF-I rose after 14 days at 1 mg twice daily [2].
Is sermorelin FDA-approved today?
No. Geref's approvals were withdrawn effective June 18, 2009, after the maker discontinued the product and asked FDA to withdraw them [5]. Sermorelin sold now is compounded and not FDA-approved [6].
Show all 8 referencesHide references
  1. Thorner M, Rochiccioli P, Colle M, Lanes R, Grunt J, Galazka A, et al. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group. J Clin Endocrinol Metab. 1996;81(3):1189-96.
  2. Corpas E, Harman SM, Piñeyro MA, Roberson R, Blackman MR. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab. 1992;75(2):530-5.
  3. Vittone J, Blackman MR, Busby-Whitehead J, Tsiao C, Stewart KJ, Tobin J, et al. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men. Metabolism. 1997;46(1):89-96.
  4. Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-57.
  5. Federal Register :: Request Access.
  6. Official web page.
  7. Wilton P, Chardet Y, Danielson K, Widlund L, Gunnarsson R. Pharmacokinetics of growth hormone-releasing hormone(1-29)-NH2 and stimulation of growth hormone secretion in healthy subjects after intravenous or intranasal administration. Acta Paediatr Suppl. 1993;388:10-5.
  8. Reddit participants. What's the hype on sermorelin? (r/PeptideForum). Accessed 2026-11-11.
Sermorelin reviews: evidence summary chart
Image: HealthRX.com. Full sermorelin reviews guide and sources at healthrx.com/reviews-sermorelin.